HHT
Conditions
Keywords
HHT, Tourniquet Test
Brief summary
The Tourniquet test is used as a diagnostic procedure for thrombocytopathies and vascular diseases. Currently, there is no evidence whether this test is also positive in hereditary haemorrhagic telangiectasia (HHT), a vasculopathy. The aim of this study was to investigate whether this non-invasive test could also be used as an additional diagnostic criterion in patients with HHT.
Detailed description
The Tourniquet test is used as a diagnostic procedure for thrombocytopathies and vascular diseases. Currently, there is no evidence whether this test is also positive in hereditary haemorrhagic telangiectasia (HHT), a vasculopathy. The aim of this study was to investigate whether this non-invasive test could also be used as an additional diagnostic criterion in patients with HHT.
Interventions
DIAGNOSTIC_TESTTourniquet Test
Tourniquet Test was performed in patients with HHT
Sponsors
University Hospital, Essen
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* In patients with confirmed HHT diagnosis (≥ 3 Curaçao criteria or positive molecular genetics) * aged over 18 years
Exclusion criteria
* if inclusion criteria does not apply
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| number of positive Tourniquet Test results in HHT patients | three years | Documentation of the number of positive Tourniquet Test results in HHT patients |
Countries
Germany
Outcome results
None listed